Literature DB >> 21394550

Glucose and insulin modify thrombospondin 1 expression and secretion in primary adipocytes from diet-induced obese rats.

Diego F Garcia-Diaz1, Arianna V Arellano, Fermin I Milagro, Maria Jesus Moreno-Aliaga, Maria Puy Portillo, J Alfredo Martinez, Javier Campion.   

Abstract

Thrombospondin 1 (TSP-1), an antiangiogenic factor and transforming growth factor (TGF)-β activity regulator, has been recently recognized as an adipokine that correlates with obesity, inflammation and insulin resistance processes. In the present study, epididymal adipocytes of rats that were fed a chow or a high-fat diet (HFD) for 50 days were isolated and incubated (24-72 h) in low (5.6 mM) or high (HG; 25 mM) glucose, in the presence or absence of 1.6 nM insulin. Rats fed the HF diet showed an established obesity state. Serum TSP-1 levels and TSP-1 mRNA basal expression of adipocytes from HFD rats were higher than those from controls. Adipocytes from HFD animals presented an insulin resistance state, as suggested by the lower insulin-stimulated glucose uptake as compared to controls. TSP-1 expression in culture was higher in adipocytes from obese animals at 24 h, but when the adipocytes were treated with HG, these expression levels dropped dramatically. Later at 72 h, TSP-1 expression was lower in adipocytes from HFD rats, and no effects of the other treatments were observed. Surprisingly, the secretion levels of this protein at 72 h were increased significantly by the HG treatment in both types of adipocytes, although they were even higher in adipocytes from obese animals. Finally, cell viability was significantly reduced by HG treatment in both types of adipocytes. In summary, TSP-1 expression/secretion was modulated in an in vitro model of insulin-resistant adipocytes. The difference between expression and secretion patterns suggests a posttranscriptional regulation. The present study confirms that TPS-1 is closely associated with obesity-related mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394550     DOI: 10.1007/s13105-011-0081-7

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  42 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Use of lactate dehydrogenase release to assess changes in culture viability.

Authors:  A J Racher; D Looby; J B Griffiths
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

Review 3.  Medical consequences of obesity.

Authors:  George A Bray
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 4.  Structures of thrombospondins.

Authors:  C B Carlson; J Lawler; D F Mosher
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

5.  Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix.

Authors:  E A Jaffe; J T Ruggiero; L K Leung; M J Doyle; P J McKeown-Longo; D F Mosher
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

6.  Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes.

Authors:  D F Garcia-Diaz; J Campion; F I Milagro; N Boque; M J Moreno-Aliaga; J A Martinez
Journal:  J Mol Endocrinol       Date:  2010-04-16       Impact factor: 5.098

Review 7.  Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.

Authors:  A W Ferrante
Journal:  J Intern Med       Date:  2007-10       Impact factor: 8.989

8.  Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferation.

Authors:  Laura A Maile; Lee B Allen; Christopher F Hanzaker; Katherine A Gollahon; Paul Dunbar; David R Clemmons
Journal:  Exp Diabetes Res       Date:  2010-06-20

9.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

10.  Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat.

Authors:  Olga I Stenina; Irene Krukovets; Kai Wang; Zhongmin Zhou; Farhad Forudi; Marc S Penn; Eric J Topol; Edward F Plow
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

View more
  6 in total

1.  Effects of hyperoxia exposure on metabolic markers and gene expression in 3T3-L1 adipocytes.

Authors:  P Quintero; P González-Muniesa; D F García-Díaz; J A Martínez
Journal:  J Physiol Biochem       Date:  2012-04-26       Impact factor: 4.158

2.  Multiple microRNAs derived from chemically synthesized precursors regulate thrombospondin 1 expression.

Authors:  Afzal M Dogar; Giuseppe Semplicio; Boris Guennewig; Jonathan Hall
Journal:  Nucleic Acid Ther       Date:  2014-01-20       Impact factor: 5.486

3.  Maternal plasma protein profiles in response to oral 50-gram glucose load in mid-pregnancy: a pilot study.

Authors:  Daniel A Enquobahrie; Chun-Fang Qiu; Karin Hevner; Dejene Abetew; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2011-08-15

4.  Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Xinyu Qi; Heather Norman; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

5.  Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.

Authors:  Taesik Gwag; Raja Gopal Reddy Mooli; Dong Li; Sangderk Lee; Eun Y Lee; Shuxia Wang
Journal:  JHEP Rep       Date:  2020-10-09

6.  Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes.

Authors:  Wilco W M Fleuren; Margot M L Linssen; Erik J M Toonen; Gerard C M van der Zon; Bruno Guigas; Jacob de Vlieg; Wim H A Dokter; D Margriet Ouwens; Wynand Alkema
Journal:  Arch Physiol Biochem       Date:  2013-03-19       Impact factor: 4.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.